Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News
  5. GSK publishes provisional 2021 dividend dates

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GSK publishes provisional 2021 dividend dates

27 Nov 2020 14:58

RNS Number : 8076G
GlaxoSmithKline PLC
27 November 2020
 

GlaxoSmithKline plc

 

GSK publishes provisional dividend dates

 

 

GSK announces the following dividend dates for 2021:

 

Results

Announcement date

Ex-dividend date

Record date

Last date for DRIP elections

Payable

Q1 2021

Wednesday 28 April 2021

Thursday 20 May 2021

Friday 21 May 2021

 

Thursday 17 June 2021

 

Thursday 8 July 2021

Q2 2021

Wednesday 28 July 2021

Thursday 19 August 2021

Friday 20 August 2021

Thursday 16 September 2021

Thursday 7 October 2021

Q3 2021

Wednesday 27 October 2021

Thursday 18 November 2021

Friday 19 November 2021

Monday 20 December 2021

Thursday 13 January 2022

Q4 2021

(Final)

Wednesday 9 February 2022

Thursday 24 February 2022

Friday 25 February 2022

Thursday 17 March 2022

Thursday 7 April 2022

 

These dates are indicative and may be subject to change.

 

 

 

 

V A Whyte

Company Secretary

 

27 November 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFESLRLDFII
67891011121314
Date   Source Headline
14th Jul 20213:34 pmRNSDirector/PDMR Shareholding
14th Jul 20213:17 pmRNSDirector/PDMR Shareholding
13th Jul 20219:44 amRNSDirector/PDMR Shareholding
13th Jul 20219:33 amRNSDirector/PDMR Shareholding
12th Jul 202110:23 amRNSDirector/PDMR Shareholding
12th Jul 202110:18 amRNSDirector/PDMR Shareholding
9th Jul 20219:30 amRNSDirector/PDMR Shareholding
2nd Jul 202112:36 pmRNSGSK and Alector collaboration in immuno-neurology
2nd Jul 202110:41 amRNSElliott Advisors (UK) letter to GSK
1st Jul 20212:29 pmRNSTotal Voting Rights
25th Jun 20214:54 pmRNSDirector/PDMR Shareholding
24th Jun 202111:07 amRNSDirector/PDMR Shareholding
23rd Jun 202111:00 amRNSGSK to deliver step-change in growth & performance
22nd Jun 20217:00 amRNSViiV/Halozyme sign exclusive licensing agreement
14th Jun 202111:58 amRNSGSK and iTeos announce collaboration for EOS-448
11th Jun 20214:54 pmRNSDirector/PDMR Shareholding
9th Jun 20213:28 pmRNSDirector/PDMR Shareholding
4th Jun 20214:02 pmRNSGSK recommend ADR holders reject mini-tender offer
1st Jun 202111:33 amRNSTotal Voting Rights
27th May 20219:21 amRNSDirector/PDMR Shareholding
27th May 20217:00 amRNSSanofi and GSK initiate new Phase 3 clinical study
27th May 20217:00 amRNSGSK/Vir Sotrovimab FDA Emergency Use Authorization
24th May 202110:10 amRNSDirector/PDMR Shareholding
21st May 202112:58 pmRNSGSK/VIR sotrovimab receives positive EMA opinion
18th May 20211:52 pmRNSBlock listing Interim Review
18th May 20217:00 amRNSMedicago/GSK COVID-19 Vaccine Positive Ph2 Results
17th May 20217:00 amRNSSanofi/GSK COVID-19 Vaccine Positive Ph2 Results
13th May 20214:46 pmRNSDirector/PDMR Shareholding
11th May 202112:54 pmRNSDirector/PDMR Shareholding
11th May 202111:30 amRNSEMTN Prospectus
6th May 20215:50 pmRNSBoard and Committee Changes
5th May 20216:23 pmRNSResult of AGM
4th May 20214:29 pmRNSTotal Voting Rights
28th Apr 20215:33 pmRNSDirector/PDMR Shareholding
28th Apr 202112:00 pmRNS1st Quarter Results
26th Apr 20214:14 pmRNSDirector/PDMR Shareholding
23rd Apr 20213:00 pmRNSEU approves GSK’s JEMPERLI (dostarlimab-gxly)
23rd Apr 20217:00 amRNSFDA approves GSK’s JEMPERLI (dostarlimab-gxly)
16th Apr 20214:00 pmRNSDirector/PDMR Shareholding
15th Apr 20213:21 pmRNSDirector/PDMR Shareholding
15th Apr 202110:17 amRNSDirector/PDMR Shareholding
14th Apr 20212:14 pmRNSDirector/PDMR Shareholding
14th Apr 202111:58 amRNSDirector/PDMR Shareholding
12th Apr 20215:32 pmRNSDirector/PDMR Shareholding
12th Apr 20219:48 amRNSDirector/PDMR Shareholding
9th Apr 20215:34 pmRNSDirector/PDMR Shareholding
9th Apr 20211:35 pmRNSDirector/PDMR Shareholding
6th Apr 20212:30 pmRNSDirectorate Change
1st Apr 20213:36 pmRNSTotal Voting Rights
30th Mar 20214:21 pmRNSPublication of 2021 AGM Notice
67891011121314

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.